APA
Fruchart J., Santos R. D., Aguilar-Salinas C., Aikawa M., Al Rasadi K., Amarenco P., Barter P. J., Ceska R., Corsini A., Després J., Duriez P., Eckel R. H., Ezhov M. V., Farnier M., Ginsberg H. N., Hermans M. P., Ishibashi S., Karpe F., Kodama T., Koenig W., Krempf M., Lim S., Lorenzatti A. J., McPherson R., Nuñez-Cortes J. M., Nordestgaard B. G., Ogawa H., Packard C. J., Plutzky J., Ponte-Negretti C. I., Pradhan A., Ray K. K., Reiner Ž., Ridker P. M., Ruscica M., Sadikot S., Shimano H., Sritara P., Stock J. K., Su T., Susekov A. V., Tartar A., Taskinen M., Tenenbaum A., Tokgözoğlu L. S., Tomlinson B., Tybjærg-Hansen A., Valensi P., Vrablík M., Wahli W., Watts G. F., Yamashita S., Yokote K., Zambon A. & Libby P. (20200224). The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. : Cardiovascular diabetology.
Chicago
Fruchart Jean-Charles, Santos Raul D, Aguilar-Salinas Carlos, Aikawa Masanori, Al Rasadi Khalid, Amarenco Pierre, Barter Philip J, Ceska Richard, Corsini Alberto, Després Jean-Pierre, Duriez Patrick, Eckel Robert H, Ezhov Marat V, Farnier Michel, Ginsberg Henry N, Hermans Michel P, Ishibashi Shun, Karpe Fredrik, Kodama Tatsuhiko, Koenig Wolfgang, Krempf Michel, Lim Soo, Lorenzatti Alberto J, McPherson Ruth, Nuñez-Cortes Jesus Millan, Nordestgaard Børge G, Ogawa Hisao, Packard Chris J, Plutzky Jorge, Ponte-Negretti Carlos I, Pradhan Aruna, Ray Kausik K, Reiner Željko, Ridker Paul M, Ruscica Massimiliano, Sadikot Shaukat, Shimano Hitoshi, Sritara Piyamitr, Stock Jane K, Su Ta-Chen, Susekov Andrey V, Tartar André, Taskinen Marja-Riitta, Tenenbaum Alexander, Tokgözoğlu Lale S, Tomlinson Brian, Tybjærg-Hansen Anne, Valensi Paul, Vrablík Michal, Wahli Walter, Watts Gerald F, Yamashita Shizuya, Yokote Koutaro, Zambon Alberto and Libby Peter. 20200224. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. : Cardiovascular diabetology.
Harvard
Fruchart J., Santos R. D., Aguilar-Salinas C., Aikawa M., Al Rasadi K., Amarenco P., Barter P. J., Ceska R., Corsini A., Després J., Duriez P., Eckel R. H., Ezhov M. V., Farnier M., Ginsberg H. N., Hermans M. P., Ishibashi S., Karpe F., Kodama T., Koenig W., Krempf M., Lim S., Lorenzatti A. J., McPherson R., Nuñez-Cortes J. M., Nordestgaard B. G., Ogawa H., Packard C. J., Plutzky J., Ponte-Negretti C. I., Pradhan A., Ray K. K., Reiner Ž., Ridker P. M., Ruscica M., Sadikot S., Shimano H., Sritara P., Stock J. K., Su T., Susekov A. V., Tartar A., Taskinen M., Tenenbaum A., Tokgözoğlu L. S., Tomlinson B., Tybjærg-Hansen A., Valensi P., Vrablík M., Wahli W., Watts G. F., Yamashita S., Yokote K., Zambon A. and Libby P. (20200224). The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. : Cardiovascular diabetology.
MLA
Fruchart Jean-Charles, Santos Raul D, Aguilar-Salinas Carlos, Aikawa Masanori, Al Rasadi Khalid, Amarenco Pierre, Barter Philip J, Ceska Richard, Corsini Alberto, Després Jean-Pierre, Duriez Patrick, Eckel Robert H, Ezhov Marat V, Farnier Michel, Ginsberg Henry N, Hermans Michel P, Ishibashi Shun, Karpe Fredrik, Kodama Tatsuhiko, Koenig Wolfgang, Krempf Michel, Lim Soo, Lorenzatti Alberto J, McPherson Ruth, Nuñez-Cortes Jesus Millan, Nordestgaard Børge G, Ogawa Hisao, Packard Chris J, Plutzky Jorge, Ponte-Negretti Carlos I, Pradhan Aruna, Ray Kausik K, Reiner Željko, Ridker Paul M, Ruscica Massimiliano, Sadikot Shaukat, Shimano Hitoshi, Sritara Piyamitr, Stock Jane K, Su Ta-Chen, Susekov Andrey V, Tartar André, Taskinen Marja-Riitta, Tenenbaum Alexander, Tokgözoğlu Lale S, Tomlinson Brian, Tybjærg-Hansen Anne, Valensi Paul, Vrablík Michal, Wahli Walter, Watts Gerald F, Yamashita Shizuya, Yokote Koutaro, Zambon Alberto and Libby Peter. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation. : Cardiovascular diabetology. 20200224.